source
- A CAR-T biotech’s dramatic turnaround, and drugmakers’ tactics to drive more scriptsThis week on "The Readout LOUD": a CAR-T biotech's dramatic turnaround, and drugmakers' tactics to drive more scripts. Listen now.STAT · 3mo ago↗ source
- STAT+: Trump celebrates closing first round of drug pricing deals, promises more aheadA deal with Regeneron was the last of 17 initially sought by the White House.STAT · 3mo ago↗ source
- FDA approves Regeneron’s hearing loss gene therapyOtarmeni, now cleared to treat a rare, inherited kind of hearing loss, is the first gene therapy cleared under the FDA’s “national priority” voucher program and will be offered to eligible patients…BioPharma Dive · 3mo ago↗ source